Medicines Co. (MDCO) Posts Surprise Q1 Profit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Medicines Co. (MDCO) Posts Surprise Q1 Profit

The Medicines Company Reports First Quarter 2015 Financial Results and Operational Developments

May 5, 2015 7:10 AM EDT

Company records six regulatory approvals in US and EU in 2015

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today announced financial results for the first quarter of 2015 and operational developments for 2015.

Operational highlights:

IONSYS® on April 30, 2015, the FDA approved IONSYS® (fentanyl iontophoretic transdermal system), the first needle-free, patient-controlled, pre-programmed fentanyl delivery system, for the short-term management of acute post-operative pain in adult patients requiring opioid analgesia in the hospital. Raplixa - on April 30, 2015 the FDA approved RAPLIXA (fibrin sealant) and the... More